• Establishment Labs Holdings Inc ESTA.OQ reported a quarterly adjusted loss of 38 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -59 cents. The mean expectation of nine analysts for the quarter was for a loss of 53 cents per share. Wall Street expected results to range from -59 cents to -48 cents per share.

• Revenue rose 33.7% to $53.78 million from a year ago; analysts expected $52.01 million.

• Establishment Labs Holdings Inc's reported EPS for the quarter was a loss of 38 cents​.

• The company reported a quarterly loss of $11.15 million.

• Establishment Labs Holdings Inc shares had risen by 20.5% this quarter and gained 7.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 10.6% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Establishment Labs Holdings Inc is $60.00, about 17.7% above its last closing price of $49.40

This summary was machine generated from LSEG data November 5 at 03:11 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)